LimaCorporate Announces FDA Approval for an Ide Study on Smr S...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
UDINE, Italy, Nov. 20, 2020 /PRNewswire-AsiaNet/ -- LimaCorporate is proud to announce that the U.S. Food and Drug Administration (FDA) has approved the Investigational Device Exemption (IDE) to start the clinical trial of the SMR Stemless Reverse Shoulder System.Logo - https://mma.prnewswire.c...
Authors: LATEST ASIANET NEWS RELEASES